Neonatology Clinical Research Symposium is organized by Children's Hospital of Philadelphia (CHOP) and will be held during May 09 - 10, 2018 at Union League of Philadelphia, Philadelphia, Pennsylvania, United States of America. This CME Conference has been approved for a maximum of 10.25 AMA PRA Category 1 Credits.
Conference Description:
Evidence-based medicine (EBM) is of increasing importance in neonatal practice. This
conference addresses key elements of the design, interpretation and application of innovative randomized clinical trials in Neonatology. The international faculty are distinguished experts in clinical and translational research in neonatal-perinatal medicine. Since EBM has several components, the conference ranges broadly. An early consideration is “What should be the end-points of valid trials?” This topic is addressed by Professor Gordon Guyatt (Canada) who coined the term “EBM” and is a widely cited researcher.
Since both clinical and research work hinges on ethically obtained informed consent, this is discussed in several ways: clinical counseling of parents of extremely preterm infants; building a trusting research relationship; and obtaining consent in emergency delivery room settings.
Professor Peter Davis (Australia) is a well-known trialist and leads a session focused on
delivery room care. Outcomes of our care, including economic problems, will be discussed. Results of trials performed in the developed world may not apply to low-resourced countries. The well-known Professor Alan Jobe will address such problems in the “Knisely Lecture.” A key problem is how knowledge from many subjects in large trials is applied to an individual infant. Professor Roger Soll (USA), of Cochrane and Vermont Oxford Network, will provide insights on this. Innovative approaches to individualizing care scientifically, including n-of-1 trials, will be discussed.
Conference Objectives:
Upon completion of this conference, the participant will be able to:
• Discuss how current dilemmas in evidence-based medicine in newborn care have evolved
• Discuss innovative approaches to parents to obtain informed consent
• Apply knowledge from large patient trials to individual patients
Additional details will be posted as soon as they are available.